Meridian Bioscience (VIVO) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.74 -9.75%
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
CRMT, REPL, HURC, More
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.03 better than the analyst estimate of $0.17. Revenue for the quarter came in at $51.5 million versus the consensus estimate of $53.1 million.
GUIDANCE:
Meridian Bioscience sees FY2019 EPS of $0.74-$0.76, versus the consensus of $0.76.
- Net revenues Flat-2% growth
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
